Project Submission page
Submit your project through the online submission tool available here below. We recommend to use Google Chrome when uploading your project.
Please be informed you will need to create a user profile before being able to submit your project. Once you have created your user profile, you will be able to submit your project.
Useful tip!
You will be able to start and save your project and submit it a a later stage when your project is totally finalised.
Deadline
- Project Submission Extended Deadline: Monday, 04 January 2027, midnight CET
Participation requirements
Who can apply?
The candidate must fulfill all criteria below:
- be a natural person
- be a member of the BHS
- may not be an employee of the parmaceutical industry
The BHS encourages projects that:
- involves a multidisciplinary team: the project must be supervised by a hematologist but the project leader can be one paramedical professional practicing in a hospital setting (ie. nurse, social worker, pharmacist, physiotherapist)
- consults patients or patient organisations
Which projects are eligible?
- The project must focus on improving patient support, well-being and/or clinical outcomes during cancer treatment in patients with hematological malignancies.
- Projects that improve the patient experience, strengthen supportive care, enhance continuity of care, and contribute to improved clinical outcomes.
- Eligible projects may be clinical, organizational, multidisciplinary, digital, or based on real-world data, provided they demonstrate a clear link with hematology care in the hospital or outpatient setting.
Application requirements?
- Description of the research project including costs and timeframe (max. 2 pages) - Example project submission AZpire award 2027.docx
- Letter of support by a promotor from the department where the research will be performed (max. 1 page)
- Motivational letter (max. 1 page)
- List of publications (if applicable)
- CV
Only submission through the online form is possible. Submissions sent by e-mail will not be considered.
Award
A monetary grant of EUR 20.000 will be awarded to the winner. The results of the selection will be announced during the 2027 General Annual Meeting of the BHS. This award has been made possible with an unrestricted grant from AstraZeneca Belgium.